Bisphosphonate Preparations Currently Available in the US
|
Primary |
Nitrogen |
Dose |
Route |
Relative |
Etidronate |
Paget’s |
No |
300-750 |
Oral |
1 |
Tiludronate |
Paget’s |
No |
400 mg |
Oral |
50 |
Alendronate |
Osteoporosis |
Yes |
10 mg/day |
Oral |
1,000 |
Risedronate |
Osteoporosis |
Yes |
5 mg/day |
Oral |
1,000 |
Ibandronate |
Osteoporosis |
Yes |
2.5 mg/day |
Oral |
1,000 |
Pamidronate |
Bone |
Yes |
90 mg/3 |
IV |
1,000 – |
Zoledronate |
Bone |
Yes |
4 mg/3 |
IV |
10,000 + |
*A once-yearly infusion of zoledronic acid for the treatment of postmenopausal osteoporosis is under FDA review.
**Relative to etidronate